Seasonal Affective Disorder: Common Questions and Answers.
AI Summary
This clinical review examines seasonal affective disorder (SAD), a mood disorder characterized by depressive episodes occurring at specific times of year, typically fall or winter, with full remission in spring or summer. The study suggests that natural light exposure is a key therapeutic intervention for SAD. First-line treatments include light therapy using commercial devices delivering 2,500 to 10,000 lux for 30 to 60 minutes daily at the same time each day. The research indicates that lifestyle interventions, including increasing exposure to natural light, are recommended as part of comprehensive treatment. Risk factors include living at northern latitudes where natural light exposure is reduced during certain seasons. The study notes that dawn simulation devices are also available for treatment, suggesting the importance of morning light exposure patterns in managing mood disorders related to seasonal light variations.
Key Findings
- Light therapy delivering 2,500 to 10,000 lux for 30 to 60 minutes daily at the same time is typically effective for treating seasonal affective disorder
- Lifestyle interventions including increasing exposure to natural light are recommended as part of treatment
- Living at more northern latitudes is identified as a possible risk factor for seasonal affective disorder
- Dawn simulation devices are available as commercial treatment options for the condition
Abstract
Seasonal affective disorder is a mood disorder that is a subtype or qualifier of major depressive disorder or bipolar disorder in the Diagnostic and Statistical Manual of Mental Disorders. It is characterized by depressive symptoms that occur at a specific time of year (typically fall or winter) with full remission at other times of year (typically spring or summer). Possible risk factors include family history, female sex, living at a more northern latitude, and young adulthood (18 to 30 years of age). With the temporal nature of the mood episodes, diagnosis requires full remission when the specified season ends and two consecutive years of episodes in the same season. First-line therapy for seasonal affective disorder includes light therapy, antidepressants, and cognitive behavior therapy, alone or in combination. Commercial devices are available for administering light therapy or dawn simulation. The light intensity and duration of treatment depend on the device and the patient's initial response, but 2,500 to 10,000 lux for 30 to 60 minutes at the same time every day is typically effective. Lifestyle interventions, such as increasing exercise and exposure to natural light, are also recommended. If seasonal affective disorder recurs, long-term treatment or preventive intervention is typically indicated, and bupropion appears to have the strongest evidence supporting long-term use. Continuing light therapy or other antidepressants is likely beneficial, although evidence is inconclusive. Evidence is also inconclusive for psychotherapy and vitamin D supplementation.
Authors
Samuel V Galima, Stephen R Vogel, Adam W Kowalski
